A sub-milligram-synthesis protocol for in vitro screening of HDAC11 inhibitors
摘要:
This work demonstrated the high efficiency of a sub-milligram-synthesis based medicinal chemistry method. Totally 72 compounds, consisting a tri-substituted pyrrolidine core, were prepared. Around 0.1 mg of each compound was solid-phase synthesized. Based on the additive property of UV absorptions of unconjugated chromophores of a molecule, these compounds were quantified by UV measurement. A hit, whose IC50 value was 1.2 mu M in HDAC11 inhibition assays, highlights the applicability of the approach reported here in future optimization works. (C) 2016 Published by Elsevier Ltd.
Histone Deacetylase Inhibitors through Click Chemistry
作者:Jie Shen、Robert Woodward、James Patrick Kedenburg、Xianwei Liu、Min Chen、Lanyan Fang、Duxin Sun、Peng George Wang
DOI:10.1021/jm8005355
日期:2008.12.11
Histone deacetylase inhibitors (HDACi) are a relatively new class of chemotherapy agents. Herein, we report a click-chemistry based approach to the synthesis of HDACi. Fourteen agents were synthesized from the combination of two alkyne and seven azido precursors. The inhibition of HDAC1 and HDAC8 was then determined by in vitro enzymatic assays, after which the cytotoxicity was evaluated in the NCI human cancer cell line screen. A lead compound 5g (NSC746457) was discovered that inhibited HDAC1 at an IC50 value of 104 +/- 30 nM and proved quite potent in the cancer cell line screen with GI(50) values ranging from 3.92 mu M to 10 nM. Thus, this click HDACi design has provided a new chemical scaffold that has not only revealed a lead compound, but one which is easily amendable to further structural modifications given the modular nature of this approach.